Pharmafile Logo
Pharmafocus logo
Advanced Search
Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

News
Biogen Idec image

Mixed results for Biogen’s MS drug

January 9, 2015
Sales and Marketing Anti-LINGO-1, BIIB033, Biogen IDEC, MS, multiple sclerosis, plegridy

An experimental drug from Biogen Idec for the treatment of multiple sclerosis (MS) has shown a mixed bag of results …

News
Takeda image

Takeda trials Teva Parkinson’s drug in Japan

January 9, 2015
Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline

Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …

News
Sanofi image

Sanofi and Regeneron post positive alirocumab results

January 9, 2015
Sales and Marketing Regeneron, Sanofi, cholesterol, heart, statin, statins

The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …

News
jo_brook

Ashfield Meetings & Events makes two appointments

January 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meetings, ashfield, events, ian anderson, jo brook

Healthcare event management firm Ashfield Meetings & Events has appointed Jo Brook as an engagement director and Ian Anderson joins …

Appointment
Sativex image

Late-stage failure for Otsuka and GW cancer pain drug

January 9, 2015
Sales and Marketing Cancer, Epidiolex, GW, MS, NICE, Otsuka, Sativex, cannabidiol, nabiximols

Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary endpoint in its first Phase III …

News
Novartis image

Novartis seeks FDA approval for lung drugs

January 8, 2015
Sales and Marketing Advair, FDA, GSK, NVA237, Novartis, QVA149, Seretide, asthma, lung copd

Novartis has submitted two new lung treatments for FDA approval after ‘robust’ Phase III trial results. If approved, QVA149 and …

News
23andme image

Genentech makes $10m gene testing outlay

January 8, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …

News
Sandoz image

Sandoz earns historic first FDA biosimilar vote

January 8, 2015
Sales and Marketing FDA, Humira, Novartis, Sandoz, Zarxio, filgrastim, zarzio

Sandoz has taken a huge step forward in the race to be the first company to market a biosimilar in …

News
Janssen image

Isis and J&J sign RNA deal

January 8, 2015
Research and Development, Sales and Marketing Isis, J&J, JJ, Janssen, RNA, gastrointestinal tract

Isis Pharmaceuticals is collaborating with Johnson & Johnson’s pharma unit Janssen to develop antisense drugs to treat autoimmune disorders. The …

News
NHS image

NHS searches for healthcare innovators

January 8, 2015
Medical Communications, Sales and Marketing NHS, UK, innovation, programme, sir bruce keogh

NHS England and medical director Sir Bruce Keogh have launched an NHS Innovation Accelerator Programme. The initiative will invite healthcare …

News
darren_carroll

Lilly appoints head of business development

January 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing darren carroll, lilly

Eli Lilly has promoted Darren Carroll to senior vice president of its corporate business development unit. Carroll has fulfilled the …

Appointment
Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

News

Gilead acquires Phenex liver disease drugs

January 7, 2015
Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex

Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …

News
Amgen image

Amgen and Novartis start cancer immunotherapy push

January 7, 2015
Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …

News
danielle_guildford

Liberation Unlimited promotes Danielle Guildford-Sharp

January 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, Danielle Guildford-Sharp, health unlimited, liberation unlimited

UK marketing and communications agency Liberation Unlimited has promoted Danielle Guildford-Sharp to the role of account manager. Since joining Liberation …

Appointment

Director General of EFPIA: “Pan-European HTA necessary”

January 6, 2015

London, January 5 2015: Richard Bergström, Director General, EFPIA argued passionately in favour of the homogenisation of European HTA bodies …

News
Press release
Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

News

Pfizer buys vaccine developer Redvax

January 6, 2015
Research and Development, Sales and Marketing Pfizer, Vaccine, cmv, herpes, redbiotec, redvax, virus

Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …

News
BMS image

BMS launches new fibrosis research collaboration

January 6, 2015
Research and Development, Sales and Marketing BMS, BMS-986020, calibr, california, fibrosis, fibrotic

Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026